Lyotropic liquid crystal injection for soft tissue regeneration and vascularization promotion and preparation method thereof
A technology of lyotropic liquid crystals and injections, which is applied in the direction of cardiovascular system diseases, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., which can solve the problem of difficult release, limited application, and rarely used macromolecular protein drugs and other issues, to achieve the effect of enhancing the efficacy, prolonging the action time, and good biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1~5、 comparative example 1~4
[0056] The present invention provides a lyotropic liquid crystal injection for soft tissue regeneration and vascularization promotion. The components of Examples 1-5 and Comparative Examples 1-4 are shown in Table 1.
[0057] Table 1 embodiment 1~5 and comparative example 1~4 prescription composition
[0058]
[0059] The preparation method of the above-mentioned lyotropic liquid crystal injection for soft tissue regeneration and vascularization is as follows:
Embodiment 1~4
[0061] According to the composition of Examples 1 to 4 in Table 1, the hydration regulator (wherein Examples 1 to 3 are octyl glucoside OG, and Example 4 is hexyl-β-D-glucopyranoside) was dissolved in N, N-dimethylacetamide (DMAC); dissolving vascular endothelial growth factor in aqueous solution; mixing molten lipid with N,N-dimethylacetamide solution of octyl glucoside to form a liquid crystal carrier; finally mixing the liquid crystal carrier with The vascular endothelial growth factor aqueous solution was mixed and shaken until clear and transparent, and the lyotropic liquid crystal precursor solutions of Examples 1-4 were obtained.
Embodiment 5~6
[0065] According to the composition of Examples 5-6 in Table 1, octyl glucoside was dissolved in ethanol (EtOH); vascular endothelial growth factor was dissolved in an aqueous solution; molten lipid was mixed with an ethanol solution of octyl glucoside to form a liquid crystal carrier; Finally, the liquid crystal carrier was mixed with the aqueous solution of vascular endothelial growth factor, and shaken until clear and transparent, thus obtaining the lyotropic liquid crystal precursor solutions of Examples 5-6.
PUM
Property | Measurement | Unit |
---|---|---|
Wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com